Skip Navigation

Testing for malaria reduces overprescription by over 70%

Using malaria RDTs in drug shops in a highly endemic region in Uganda substantially reduced overdiagnosis of malaria, improving the use of valuable drugs, according to a new study published in PLOS ONE.

Malaria research publications

Browse through more than 80 journal articles published by ACT Consortium investigators on the access, targeting, safety and quality of antimalarials.

News from our Partners

The recording of the "Quality of malaria rapid diagnostic testing" webinar is now available. The event included panelists from the WHO, Foundation for Innovative New Diagnostics and Standard Diagnostics.

Videos and more

Visit our multimedia section to watch videos and animations, browse a prezi and listen to podcasts with ACT Consortium investigators talking about their studies on the access, targeting, quality and safety of ACT drugs.

View all ACT Consortium news

The ACT Consortium is an international research collaboration formed in November 2007 to answer key questions on malaria drug delivery in Africa and Asia.  

Our goal is to develop and evaluate delivery mechanisms to improve ACT access, targeting, safety and quality. 

The ACT Consortium is funded by the Bill & Melinda Gates Foundation and has partners throughout Africa, Asia, Europe and the United States.  It is coordinated through the London School of Hygiene & Tropical Medicine.